University of Sydney Feb 25 2026 Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments. Globally, TB remains a major health crisis, claiming around 1.2 million lives each year and ranking among the world's deadliest infectious diseases. The rise of drug-resistant strains, including in the Asia-Pacific region,

Tag-uri: Medicamente